Status:

UNKNOWN

hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

Lead Sponsor:

University Hospital Heidelberg

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

Brief Summary

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of unselected p...

Eligibility Criteria

Inclusion

  • documented atrial fibrillation
  • availability of at least one hsTnT measurement

Exclusion

  • none

Key Trial Info

Start Date :

September 14 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2020

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT03344237

Start Date

September 14 2017

End Date

March 1 2020

Last Update

September 27 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital

Heidelberg, Baden-Wurttemberg, Germany, 69120